Greek Validation of ACE III Test in Perioperative Patients
Addenbrooke's Cognitive Examination III Scale as a Screening Tool for Cognitive Impairment in Surgical Population: Validity and Reliability of the Culturally Adapted Greek Version
1 other identifier
observational
128
1 country
1
Brief Summary
Postoperative neurocognitive disorders, including postoperative delirium (POD) and postoperaive cognitive dysfunction (POCD), are common complications of perioperative neurocognition in elderly patients undergoing surgery. POD and POCD have short- and long-term consequences, such as increased hospital stays and costs, augmented morbidity and mortality, as well as higher risk for cognitive decline later in life. Therefore, early prevention and diagnosis of these conditions is of great importance. A number of psychometric tests have been proposed as cognitive screening tools. Given the fact that many of them show weaknesses and difficulties in performance, scientists have sought for more useful alternatives. Montreal Cognitive Assessment (MoCA) is considered to be a good choice, as it has been successfully applied in the perioperative setting. What's more, it has been translated and validated for a Greek population with neurological disorders. Addenbrooke's Congnitive Examination III (ACE III) has been introduced recently into clinical practice. It is an easy to perform and detailed test that covers several neurocognitive domains and has shown high sensitivity and specificity in clinical conditions, including dementia and Alzheimer's disease. Although current literature lacks data concerning its perioperative use, ACE III could prove useful for screening patients undergoing surgery and anesthesia on the basis of its favorable characteristics as mentioned above. The aim of this study is to translate the ACE III (English version 2012) into Greek and assess its validity in perioperative patients aged \>55 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2020
CompletedFirst Posted
Study publicly available on registry
March 18, 2020
CompletedStudy Start
First participant enrolled
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 18, 2022
CompletedJune 3, 2024
May 1, 2024
2 months
March 16, 2020
May 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cultural adaption
Cultural adaption of ACE III (English version 2012) into the Greek language
2 months
Validation
Construct and convergent validity of the translated version of ACE III into the Greek language
2 months
Study Arms (2)
Controls
Participants scheduled for surgery with MoCA score ≥ 26 preoperatively
Patients
Participants scheduled for surgery with MoCA score \< 26 preoperatively
Eligibility Criteria
128 surgical patients (cognitively and non-cognitively impaired)
You may qualify if:
- Patients scheduled for surgical intervention
- At least of primary level of education
You may not qualify if:
- Neurodegenerative disease
- Cerebrovascular disease
- Psychiatric disorders
- History of head injury
- Use of medication affecting the CNS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AHEPA University Hospital
Thessaloniki, 54636, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Zouka, MD
AHEPA University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant - Principal Investigator
Study Record Dates
First Submitted
March 16, 2020
First Posted
March 18, 2020
Study Start
October 15, 2021
Primary Completion
November 30, 2021
Study Completion
December 18, 2022
Last Updated
June 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share